for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Surrozen Inc

SRZNW.OQ

Latest Trade

1.92USD

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

0.60

 - 

2.99

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
1.92
Open
--
Volume
--
3M AVG Volume
5.20
Today's High
--
Today's Low
--
52 Week High
2.99
52 Week Low
0.60
Shares Out (MIL)
37.33
Market Cap (MIL)
317.70
Forward P/E
-3.60
Dividend (Yield %)
--

Latest Developments

More

Surrozen Inc Reports Q3 Loss Per Share $0.51

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Surrozen Inc

Surrozen Inc., formerly Consonance-HFW Acquisition Corp., is a preclinical stage biopharmaceutical company. The Company is engaged in discovering and developing biologic drug candidates to selectively modulate the Wnt pathway in a range of organs and tissues. Its two technologies, Surrozen Wnt signal Activating Protein (SWAP) and Surrozen Wnt signal Enhancer Engineered for Tissue Specificity (SWEETS), enable to selectively modulate Wnt signaling through the generation of Wnt and R-spondin mimetics. Its SWAP molecules are designed to mimic the activity of naturally occurring Wnt proteins. SWEETS molecules are designed to body's response to naturally occurring Wnt proteins. The Company's two lead product candidates include SZN-1326 and SZN-043. SZN-1326 is in development for moderate to severe inflammatory bowel disease (IBD) with ulcerative colitis (UC). SZN-043 is in development for severe alcoholic hepatitis (AH).

Industry

Business Services

Contact Info

171 Oyster Point Blvd, Suite 400

SOUTH SAN FRANCISCO, CA

94080

United States

+1.650.4752820

https://www.surrozen.com

Key Stats

1.00 mean rating - 3 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2021(E)

0.0K
EPS (USD)

2021(E)

-2.433
Price To Earnings (TTM)
--
Price To Sales (TTM)
--
Price To Book (MRQ)
1.30
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
--
Return on Equity (TTM)
--

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up